Two cases of delayed onset of immune-related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer.
Yasutomo NakaiTomoyuki OtsukaTakako InoueTakatoshi NawaKoji HatanoYoshiyuki YamamotoAkira NagaharaMasashi NakayamaKen-Ichi KakimotoKazuo NishimuraPublished in: IJU case reports (2021)
Two patients with delayed onset of immune-related adverse events after nivolumab discontinuation were recovered with immunosuppressive treatment.
Keyphrases